Rights and permissions
About this article
Cite this article
Drotrecogin-alfa relatively cost effective in severe sepsis. Pharmacoecon. Outcomes News 383, 5 (2002). https://doi.org/10.1007/BF03279687
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279687